{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T04:06:37Z","timestamp":1747454797169,"version":"3.40.5"},"reference-count":42,"publisher":"Consilium Medicum","issue":"1","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Aim. To systematically analyze existing publications from available scientific databases (PubMed, Cochrane, eLibrary) for the period from 2018 to 2023 on the treatment of fever in children and adults with metamizole sodium (MS).\r\nMaterials and methods. A systematic review of scientific publications on the efficacy and safety of MS therapy for fever in adults and children compared to non-steroidal anti-inflammatory drugs was conducted. Six randomized clinical trials involving 884 patients (101 adults and 783 children) were included in the analysis.\r\nResults. In all studies, MS has been demonstrated to be effective in reducing fever in both children and adults when used for short-term therapy. MS is superior to paracetamol, ibuprofen, acetylsalicylic acid and not inferior to nimesulide and propacetamol in terms of effectiveness in reducing body temperature between 1.5 and 6.0 hours after oral intake. It has been shown that treatment of fever with MS is a safer strategy compared to other non-steroidal anti-inflammatory drugs, as it has no clinically significant risks of gastric mucosal irritation, development of gastrointestinal bleeding and erosions. It has been established that therapeutic doses of MS do not lead to an increase in blood pressure, and in some cases contribute to hypotensive effect, especially in fever in adult comorbid patients with arterial hypertension.\r\nConclusion. MS is an effective treatment for fever in children and adults.<\/jats:p>","DOI":"10.26442\/00403660.2025.01.203101","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T23:31:26Z","timestamp":1740094286000},"page":"71-79","source":"Crossref","is-referenced-by-count":0,"title":["A systematic review on the safety and efficacy of metamizole sodium as a therapy for the treatment of fever in children and adults"],"prefix":"10.26442","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6128-5914","authenticated-orcid":false,"given":"Andrey G.","family":"Malyavin","sequence":"additional","affiliation":[{"name":"Russian University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6571-1220","authenticated-orcid":false,"given":"Sergei L.","family":"Babak","sequence":"additional","affiliation":[{"name":"Semashko Research Institute of Clinical Medicine of the Russian University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1303-8318","authenticated-orcid":false,"given":"Andrey L.","family":"Zaplatnikov","sequence":"additional","affiliation":[{"name":"Russian Medical Academy of Continuous Professional Education"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4861-0919","authenticated-orcid":false,"given":"Vilya \u0410.","family":"Bulgakova","sequence":"additional","affiliation":[{"name":"Petrovsky National Research Center of Surgery"},{"name":"Pirogov Russian National Research Medical University (Pirogov University)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7386-8788","authenticated-orcid":false,"given":"Marina Y.","family":"Garusova","sequence":"additional","affiliation":[{"name":"Opella Healthcare LLC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2265-4107","authenticated-orcid":false,"given":"Mariya D.","family":"Ilyukhina","sequence":"additional","affiliation":[{"name":"Sechenov First Moscow State Medical University (Sechenov University)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"unstructured":"Balli S, Shumway KR, Sharan S. Physiology, Fever. StatPearls Publishing, 2024. PMID:32966005","key":"ref1"},{"doi-asserted-by":"publisher","key":"ref2","DOI":"10.1596\/978-1-4648-0348-2_ch8"},{"doi-asserted-by":"publisher","key":"ref3","DOI":"10.15690\/pf.v20i2.2539"},{"unstructured":"\u0411\u0430\u0440\u0430\u043d\u043e\u0432 \u0410.\u0410., \u0411\u0443\u043b\u0433\u0430\u043a\u043e\u0432\u0430 \u0412.\u0410., \u0412\u0438\u0448\u043d\u0435\u0432\u0430 \u0415.\u0410., \u0438 \u0434\u0440. \u041b\u0438\u0445\u043e\u0440\u0430\u0434\u043a\u0430 \u0443 \u0434\u0435\u0442\u0435\u0439. \u0420\u0443\u043a\u043e\u0432\u043e\u0434\u0441\u0442\u0432\u043e \u0434\u043b\u044f \u0432\u0440\u0430\u0447\u0435\u0439. \u041c.: \u041f\u0435\u0434\u0438\u0430\u0442\u0440\u042a, 2021 [Baranov AA, Bulgakova VA, Vishneva EA, et al. Likhoradka u detei. Rukovodstvo dlia vrachei. Moscow: Pediatr\", 2021 (in Russian)].","key":"ref4"},{"doi-asserted-by":"publisher","key":"ref5","DOI":"10.1016\/S0140-6736(20)30183-5"},{"doi-asserted-by":"publisher","key":"ref6","DOI":"10.1001\/archinte.158.17.1870"},{"doi-asserted-by":"publisher","key":"ref7","DOI":"10.3389\/fmed.2023.1292468"},{"doi-asserted-by":"crossref","unstructured":"\u0422\u0430\u0442\u043e\u0447\u0435\u043d\u043a\u043e \u0412.\u041a., \u0423\u0447\u0430\u0439\u043a\u0438\u043d \u0412.\u0424. \u041b\u0438\u0445\u043e\u0440\u0430\u0434\u043a\u0430. \u041f\u0435\u0434\u0438\u0430\u0442\u0440\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u043b\u043e\u0433\u0438\u044f. 2006;3(3):43-4 [Tatochenko VK, Uchaikin VF. Fever. Pediatric Pharmacology. 2006;3(3):43-4 (in Russian)].","key":"ref8","DOI":"10.1142\/9789812772428_0006"},{"unstructured":"\u0414\u0438\u0434\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u041d.\u0410., \u0422\u0430\u043d\u0430\u0441\u043e\u0432\u0430 \u0410.\u041d. \u041b\u0438\u0445\u043e\u0440\u0430\u0434\u043a\u0430. \u0420\u041c\u0416. 2003;(4):189 [Didkovskij NA, Tanasova AN. Fever. Russian Medical Journal. 2003;(4):189 (in Russian)].","key":"ref9"},{"doi-asserted-by":"publisher","key":"ref10","DOI":"10.1001\/archinte.160.4.449"},{"unstructured":"Ghlichloo I, Gerriets V. Nonsteroidal anti-inflammatory drugs (NSAIDs). In: StatPearls Publishing, 2024. PMID:31613522","key":"ref11"},{"unstructured":"\u041c\u0443\u0431\u0430\u0440\u0430\u043a\u0448\u0438\u043d\u0430 \u041e.\u0410. \u0410\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0441\u0442\u044c \u043f\u0440\u0438\u043c\u0435\u043d\u0435\u043d\u0438\u044f \u043d\u0435\u0441\u0442\u0435\u0440\u043e\u0438\u0434\u043d\u044b\u0445 \u043f\u0440\u043e\u0442\u0438\u0432\u043e\u0432\u043e\u0441\u043f\u0430\u043b\u0438\u0442\u0435\u043b\u044c\u043d\u044b\u0445 \u0441\u0440\u0435\u0434\u0441\u0442\u0432 \u0434\u043b\u044f \u043b\u0435\u0447\u0435\u043d\u0438\u044f \u043b\u0438\u0445\u043e\u0440\u0430\u0434\u043a\u0438 \u0443 \u0434\u0435\u0442\u0435\u0439. \u0412\u043e\u043f\u0440\u043e\u0441\u044b \u0441\u043e\u0432\u0440\u0435\u043c\u0435\u043d\u043d\u043e\u0439 \u043f\u0435\u0434\u0438\u0430\u0442\u0440\u0438\u0438. 2010;9(2):156-60 [Mubarakshina OA. Topicality of nonsteroidal anti-inflammatory drugs in treatment of fever in children. Current Pediatrics. 2010;9(2):156-60 (in Russian)].","key":"ref12"},{"doi-asserted-by":"publisher","key":"ref13","DOI":"10.22141\/2224-0551.1.69.2016.73704"},{"unstructured":"\u0417\u0430\u0439\u0446\u0435\u0432\u0430 \u041e.\u0412., \u041b\u043e\u043a\u0448\u0438\u043d\u0430 \u042d.\u042d. \u0421\u0440\u0430\u0432\u043d\u0438\u0442\u0435\u043b\u044c\u043d\u044b\u0435 \u0430\u0441\u043f\u0435\u043a\u0442\u044b \u044d\u0444\u0444\u0435\u043a\u0442\u0438\u0432\u043d\u043e\u0441\u0442\u0438 \u0438 \u0431\u0435\u0437\u043e\u043f\u0430\u0441\u043d\u043e\u0441\u0442\u0438 \u0430\u043d\u0430\u043b\u044c\u0433\u0435\u0442\u0438\u043a\u043e\u0432-\u0430\u043d\u0442\u0438\u043f\u0438\u0440\u0435\u0442\u0438\u043a\u043e\u0432 \u0432 \u043f\u0435\u0434\u0438\u0430\u0442\u0440\u0438\u0438. \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u0432\u0435\u0441\u0442\u043d\u0438\u043a \u043f\u0435\u0440\u0438\u043d\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u043f\u0435\u0434\u0438\u0430\u0442\u0440\u0438\u0438. 2009;54(5):86-92 [Zaitseva OV, Lokshina EE. The effectiveness and safety of analgesic antipyretics in pediatric care: Comparative aspects. Rossijskij Vestnik Perinatologii i Pediatrii. 2009;54(5):86-92 (in Russian)].","key":"ref14"},{"doi-asserted-by":"publisher","key":"ref15","DOI":"10.26442\/00403660.2020.01.000480"},{"doi-asserted-by":"publisher","key":"ref16","DOI":"10.1001\/jama.296.1.87"},{"doi-asserted-by":"publisher","key":"ref17","DOI":"10.1111\/jcpt.12422"},{"unstructured":"European Medicines Agency. Assessment report: Referral under Article 31 of Directive 2001\/83\/EC metamizole-containing medicinal products. EMA\/143912\/2019. Available at: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/metamizole-article-31-referral-chmp-assessment-report_en.pdf. Accessed: 26.11.2024.","key":"ref18"},{"doi-asserted-by":"publisher","key":"ref19","DOI":"10.52778\/efsm.22.0153"},{"doi-asserted-by":"publisher","key":"ref20","DOI":"10.1016\/s0895-4356(98)00076-6"},{"doi-asserted-by":"publisher","key":"ref21","DOI":"10.1371\/journal.pone.0122918"},{"unstructured":"European Medicines Agency. Metamizole-containing medicinal products article 107i referral \u2013 EMA recommends measures to minimise serious outcomes of known side effect with painkiller metamizole. EMA\/407900\/2024. Available at: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/metamizole-containing-medicinal-products-article-107i-referral-ema-recommends-measures-minimise-serious-outcomes-known-side-effect-painkiller-metamizole_en.pdf-0. Accessed: 20.09.2024.","key":"ref22"},{"unstructured":"European Medicines Agency. Metamizole Article-31 referral \u2013 Start of referral. EMA\/338589\/2018. Available at: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/metamizole-article-31-referral-start-referral_en.pdf. Accessed: 20.09.2024.","key":"ref23"},{"doi-asserted-by":"publisher","key":"ref24","DOI":"10.1111\/j.1600-0609.1996.tb01641.x"},{"doi-asserted-by":"publisher","key":"ref25","DOI":"10.3324\/haematol.2008.002642"},{"doi-asserted-by":"publisher","key":"ref26","DOI":"10.1111\/j.1600-0609.1996.tb01643.x"},{"doi-asserted-by":"crossref","unstructured":"Hamerschlak N, Maluf E, Biasi Cavalcanti A, et al. Incidence and risk factors for agranulocytosis in Latin American countries \u2013 the Latin Study: A multicenter study. Eur J Clin Pharmacol. 2008;64(9):921-9.","key":"ref27","DOI":"10.1007\/s00228-008-0513-7"},{"doi-asserted-by":"publisher","key":"ref28","DOI":"10.1007\/s00228-012-1386-3"},{"doi-asserted-by":"publisher","key":"ref29","DOI":"10.1016\/0140-6736(91)90744-a"},{"doi-asserted-by":"publisher","key":"ref30","DOI":"10.1097\/00042737-200302000-00011"},{"doi-asserted-by":"publisher","key":"ref31","DOI":"10.2165\/00002018-200427060-00005"},{"doi-asserted-by":"publisher","key":"ref32","DOI":"10.1136\/gut.2005.080754"},{"doi-asserted-by":"publisher","key":"ref33","DOI":"10.1186\/s12913-014-0579-0"},{"doi-asserted-by":"publisher","key":"ref34","DOI":"10.1371\/journal.pmed.1000100"},{"doi-asserted-by":"publisher","key":"ref35","DOI":"10.1177\/030006058401200207"},{"doi-asserted-by":"publisher","key":"ref36","DOI":"10.1177\/030006058801600310"},{"doi-asserted-by":"publisher","key":"ref37","DOI":"10.1177\/000992280104000602"},{"doi-asserted-by":"publisher","key":"ref38","DOI":"10.1007\/s00134-003-2087-2"},{"doi-asserted-by":"publisher","key":"ref39","DOI":"10.1590\/s1516-31802006000300005"},{"doi-asserted-by":"publisher","key":"ref40","DOI":"10.2223\/JPED.2060"},{"unstructured":"Hoign\u00e9 R, Zoppi M, Sollberger J, et al. Fall in systolic blood pressure due to metamizol (dipyrone, noramidopyrine, novaminsulfone). Results from the Comprehensive Hospital Drug Monitoring Berne (CHDMB). Agents Actions Suppl. 1986;19:189-95. PMID:3463177","key":"ref41"},{"unstructured":"Aronson JK. Meyler\u2019s Side Effects of Analgesics and Anti-Inflammatory Drugs. 1st ed. The Netherlands: Elsevier Science, 2009.","key":"ref42"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/642704\/175208","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/642704\/175208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T11:40:00Z","timestamp":1747395600000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/642704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,20]]}},"URL":"https:\/\/doi.org\/10.26442\/00403660.2025.01.203101","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"type":"electronic","value":"2309-5342"},{"type":"print","value":"0040-3660"}],"subject":[],"published":{"date-parts":[[2025,2,21]]}}}